Silver Bullet Therapeutics receives patent protecting its cannulated bone screw device

Silver Bullet Therapeutics announced that the U.S Patent and Trademark Office issued a patent for the release of antimicrobial metal ions to prevent infection.

Advertisement

The company, which develops antimicrobial implants and medical devices to address surgical site and hospital-acquired infections, now has three patents that cover substrates such as surgical meshes and sutures, and also orthopedic devices like screws and large-joint implants.

 

The company’s first product is a cannulated bone screw that aims to reduce microbial contamination for orthopedic reduction and internal fixation procedures. It is awaiting regulatory approval.

More articles on devices:

17 spine devices receive FDA 510(k) clearance in December
Amedica restructuring includes 28% staff reduction, new spine focus—5 key points
Bacterin revenue up for 5th consecutive quarter—5 things to know

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.